PEOPLE - BioTransplant (US) makes appointment:
This article was originally published in Clinica
Executive Summary
BioTransplant (Charlestown, Massachusetts), a developer of therapeutic devices and treatments for a range of medical conditions, has appointed Donald Hawthorne, Anthony Hitschler and Gregg Summerville to the board. Mr Hawthorne currently serves as BioTranspolant's president and CEO, Mr Hitschler serves as president of Brandywine Asset Management and Mr Summerville serves as chief investment strategist at Kirr, Marbach & Company.